Zyla Life Sciences's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Zyla Life Sciences (EGLT) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Zyla Life Sciences vs Its Competitors
- TTM: Trailing 12-month revenue of 43M vs -M combined for its competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-42.0% annualized vs trailing 12 months).
- Peer revenue share: Zyla Life Sciences accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
EGLT Sales vs. its Competitors, Q1 2018
Zyla Life Sciences generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
API endpoints for this dataset
For context: the Major Pharmaceutical Preparations industry grew revenue 8.9% year over year, combined, vs 15.4% for Zyla Life Sciences. Zyla Life Sciences's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.
Zyla Life Sciences's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Zyla Life Sciences | - | Yes | Yes | Yes |
| High-Confidence Competitors (2) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
EGLT Stock Performance relative to its Competitors
EGLT Stock Performance relative to High-Confidence Competitors
Zyla Life Sciences's Competitors Named by the Company
Competitive relationships identified from Zyla Life Sciences reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Collegium Pharmaceutical Inc | Company report | 85% |
| Vivos Inc | Company report | 85% |
| Bausch Health Companies Inc | Company report | 85% |
| Viatris Inc | Company report | 85% |
| Amphastar Pharmaceuticals Inc | Company report | 85% |
| Endo International Plc | Company report | 85% |
| Teva Pharmaceutical Industries Limited | Company report | 85% |
| Ani Pharmaceuticals Inc | Company report | 85% |
| Amneal Pharmaceuticals Inc | Company report | 85% |
Company report basis, confidence, active dates and source counts for Zyla Life Sciences's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.